Krajina: Grécko
Jazyk: angličtina
Zdroj: HMA (Heads of Medicines Agencies)
marbofloxacin 20 mg
Krka d.d.
QJ01MA93
Solution for injection
marbofloxacin
Cattle, Pigs
2011-02-23
1.3.1 Marbofloxacin SPC, Labeling and Package Leaflet FR SmPCPIL013709/3 20.09.2010 – Updated: 10.02.2011 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1.3.1 Marbofloxacin SPC, Labeling and Package Leaflet FR SmPCPIL013709/3 20.09.2010 – Updated: 10.02.2011 Page 2 of 6 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marbiflox 20 mg/ml solution for injection for cattle (calves) and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution for injection contains: ACTIVE SUBSTANCE: Marbofloxacin 20 mg EXCIPIENTS: Metacresol 2 mg Disodium edetate 0.10 mg Monothioglycerol 0.50 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, greenish yellow to brownish yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (Calves). Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In pre-ruminant and ruminant calves: - treatment of respiratory infections caused by sensitive strains of _Pasteurella multocida_, _Mannheimia haemolytica_, and _Mycoplasma bovis_. In pigs: - treatment of respiratory infections caused by sensitive strains of _Actinobacillus _ _pleuropneumoniae_, _Mycoplasma hyopneumoniae_, and _Pasteurella multocida_. This product should only be used based on susceptibility testing. 4.3 CONTRAINDICATIONS Do not use in case of disturbance in growth of cartilage and/or during injury of locomotion system particulary on functionally loaded joints. Do not administer in animals with known hypersensitivity to marbofloxacin or any other qui Prečítajte si celý dokument